Sigyn Therapeutics (SIGY) Times Interest Earned (2017 - 2025)
Sigyn Therapeutics (SIGY) posted Times Interest Earned of -$36.07 for Q2 2025, down 654.18% sequentially from -$4.78 in Q1 2025, and up 12.46% YoY from -$32.08 in Q2 2024.
Sigyn Therapeutics (SIGY) Times Interest Earned (2017 - 2025) Analysis & Trends
Sigyn Therapeutics has reported Times Interest Earned for 9 years, with the latest figure at -$36.07 in Q2 2025.
- Quarterly Times Interest Earned rose 12.46% year-over-year to -$36.07 in Q2 2025, while the trailing twelve-month figure through Sep 2025 was -$60.92 (up 76.14% YoY) and the FY2024 annual result came in at -$0.64, up 21.62% from the prior year.
- Times Interest Earned declined to -$36.07 in Q2 2025 per SIGY's latest filing, from -$4.78 in the prior quarter.
- Over five years, Times Interest Earned peaked at $427.44 in Q4 2023 and troughed at -$74.82 in Q3 2024.
- A 5-year average of $6.16 and a median of -$13.3 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2023: Times Interest Earned slumped 1865.1% in 2021, then soared 4612.02% in 2023.
- Over 5 years, Times Interest Earned stood at -$19.19 in 2021, then surged by 50.62% to -$9.47 in 2022, then jumped by 4612.02% to $427.44 in 2023, then plunged by 105.73% to -$24.48 in 2024, then plunged by 47.34% to -$36.07 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$36.07, -$4.78, and -$24.48 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -36.07 |
| Mar 31, 2025 | -4.78 |
| Dec 31, 2024 | -24.48 |
| Sep 30, 2024 | -74.82 |
| Jun 30, 2024 | -41.21 |
| Mar 31, 2024 | -11.62 |
| Dec 31, 2023 | 427.44 |
| Sep 30, 2023 | -22.70 |
| Jun 30, 2023 | -10.59 |
| Mar 31, 2023 | -13.30 |
| Dec 31, 2022 | -9.47 |
| Mar 31, 2022 | -12.51 |
| Dec 31, 2021 | -19.19 |
| Jun 30, 2021 | -8.15 |
| Mar 31, 2021 | -46.08 |
| Dec 31, 2020 | -0.98 |
| Sep 30, 2020 | -1.79 |
| Jun 30, 2020 | -2.67 |
| Mar 31, 2020 | -3.32 |
| Dec 31, 2019 | -0.19 |